Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2009
The United States has witnessed dramatic changes in the marketing of prescription drugs over the past decade. From one perspective, patients, exposed to a dramatic increase in direct-to-consumer (DTC) promotion of prescription medications,1 are now “consumers” of health care. The pharmaceutical industry suggests that this promotion helps patients make more informed choices.2 However, observers have questioned the benefits of DTC marketing and the balance of associated risk and benefit information.3,4
Direct-to-Consumer Offers for Free and Discounted Medications on the Internet: A Content Analysis of “e-Samples”. Arch Intern Med. 2009;169(21):2024–2030. doi:10.1001/archinternmed.2009.397
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: